|
variable
|
A group
|
B group
|
p value
|
|---|
|
(n = 466) No. (%)
|
(n = 466) No. (%)
|
|---|
|
In-hospital
|
|
Mortality
|
11(2.4)
|
9(1.9)
|
0.821
|
|
MI
|
19(4.1)
|
15(3.2)
|
0.6
|
|
Stroke
|
11(2.4)
|
7(1.5)
|
0.475
|
|
Respiratory failure
|
20(4.3)
|
15(3.2)
|
0.491
|
|
Pneumonia
|
26(5.6)
|
21(4.5)
|
0.549
|
|
AKI
|
197
|
179
|
0.532
|
|
Stage 1
|
139(29.8)
|
131(28.1)
| |
|
Stage 2
|
40(8.6)
|
35(7.5)
| |
|
Stage 3
|
18(3.9)
|
13(2.8)
| |
|
In-hospital dialysis
|
13(2.8)
|
8(1.7)
|
0.377
|
|
RBC transfusion
|
196(42.1)
|
175(37.6)
|
0.181
|
|
DSWI
|
10(2.1)
|
7(1.5)
|
0.624
|
|
LCOS
|
21(4.5)
|
25(5.4)
|
0.650
|
|
IABP application
|
18(3.9)
|
19(4.1)
|
1
|
|
Longer-term
|
|
Lost to follow-up
|
14(3.1)
|
10(2.2)
|
0.535
|
|
New onset of dialysis
|
5(1.1)
|
3(0.7)
|
0.708
|
|
Mortality
|
33(7.5)
|
37(8.3)
|
0.753
|
- MI myocardial infarction, AKI acute kidney injury, RBC red blood cell, DSWI deep sternal wound infection, LCOS low cardiac output syndrome, IABP intra-aortic balloon pump
